Compounds > 4-diphenylacetoxy-1,1-dimethylpiperidinium
Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Carcinoma, Small Cell Lung

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Carcinoma, Small Cell Lung in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, W1
Zhang, S1
Hu, C1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Carcinoma, Small Cell Lung

ArticleYear
[M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
 and Adhesion in Small Cell Lung Cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016, Volume: 19, Issue:3

    Topics: Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Piperidines;

2016